Randomized clinical trial to evaluate the effects of Pascal panretinal photocoagulation on macular nerve fiber layer: Manchester Pascal Study report 3.

To investigate the effects of panretinal photocoagulation (PRP) on macular thickness and macular nerve fiber layer thickness in eyes with proliferative diabetic retinopathy.
Single-center, randomized clinical trial (n = 40 eyes). Proliferative diabetic retinopathy was treated with 1,500 burns given as Pascal 20-millisecond single-session PRP (SS-PRP) or as multiple-session PRP (100 milliseconds, MS-PRP) over a 4-week period. The main outcome measures included optical coherence tomography measurements of total retinal thickness and nerve fiber layer at the macula, visual acuity, and proliferative diabetic retinopathy regression and were recorded at baseline, 4 weeks, and 12 weeks. Optic disk photographs were graded by masked a glaucoma specialist.
At 12 weeks, in the SS-PRP group, there was no significant change in total nerve fiber layer thickness from baseline (4 weeks; +7.2 μm, P = 0.78; 12 weeks, -1.8 μm, P = 0.95). There was a significant increase in total retinal thickness for the MS-PRP group at 4 weeks from baseline (96 ± 17 μm; P < 0.001) and at 12 weeks (56 ± 21 μm; P = 0.0167). After 4 weeks in the MS-PRP group, total nerve fiber layer thickness increased significantly by 31 ± 54 μm (P = 0.029) from baseline, with a significant reduction at 12 weeks from baseline (35 ± 63 μm; P = 0.034). There was no change among groups for optic nerve appearance postlaser. At 12 weeks, the mean visual acuity was 81 ± 6 letters (SS-PRP group), compared with 77 ± 15 letters in the MS-PRP group (95% confidence interval, 5.2 to 9 letters; P = 0.286). For the SS-PRP group, a positive effect on proliferative diabetic retinopathy regression was observed in 74% of eyes compared with 53% of the eyes in the MS-PRP group (P = 0.31).
Compared with 20-millisecond SS-PRP, eyes treated with conventional 100-millisecond single-spot delivered over multiple sessions showed increased total macular thickness at 4 weeks, with a thinning of macular nerve fiber layer at 12 weeks.
AuthorsMahiul M K Muqit, George R Marcellino, David B Henson, Cecilia H Fenerty, Paulo E Stanga
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 31 Issue 8 Pg. 1699-707 (Sep 2011) ISSN: 1539-2864 [Electronic] United States
PMID21478808 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
  • Adult
  • Diabetic Retinopathy (surgery)
  • Female
  • Fourier Analysis
  • Humans
  • Intraocular Pressure
  • Laser Coagulation
  • Male
  • Nerve Fibers (pathology)
  • Optic Disk (pathology)
  • Prospective Studies
  • Retina (surgery)
  • Retinal Ganglion Cells (pathology)
  • Tomography, Optical Coherence
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: